| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies
|
Atluri, Himachandana
|
|
|
17 |
6 |
p. 275-285
|
article
|
| 2 |
Bispecific Antibodies for the Treatment of Multiple Myeloma
|
Goldsmith, Scott R.
|
|
|
17 |
6 |
p. 286-297
|
article
|
| 3 |
Circulating Tumor DNA in Lymphoma
|
Thiruvengadam, Swetha Kambhampati
|
|
|
17 |
6 |
p. 298-305
|
article
|
| 4 |
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions
|
Scalzulli, Emilia
|
|
|
17 |
6 |
p. 198-205
|
article
|
| 5 |
Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
|
Shahrin, Nur Hezrin
|
|
|
17 |
6 |
p. 171-180
|
article
|
| 6 |
Molecular Pathogenesis of Myeloproliferative Neoplasms
|
Rolles, Benjamin
|
|
|
17 |
6 |
p. 319-329
|
article
|
| 7 |
Pediatric Germline Predisposition to Myeloid Neoplasms
|
Thompson, Christineil
|
|
|
17 |
6 |
p. 266-274
|
article
|
| 8 |
Precision Medicine in Myeloid Malignancies: Hype or Hope?
|
Upadhyay Banskota, Shristi
|
|
|
17 |
6 |
p. 217-227
|
article
|
| 9 |
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
|
Bhatt, Neel S.
|
|
|
17 |
6 |
p. 228-242
|
article
|
| 10 |
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
|
Granroth, Ginna
|
|
|
17 |
6 |
p. 243-253
|
article
|
| 11 |
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms
|
Baranwal, Anmol
|
|
|
17 |
6 |
p. 254-265
|
article
|
| 12 |
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies
|
Ng, John Joson
|
|
|
17 |
6 |
p. 181-197
|
article
|
| 13 |
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
|
McCurdy, Arleigh
|
|
|
17 |
6 |
p. 306-318
|
article
|
| 14 |
Value in Myeloma Care: Myth or Reality
|
Ouchveridze, Evguenia
|
|
|
17 |
6 |
p. 206-216
|
article
|
Journal description